These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7612500)

  • 1. Survival after treatment of advanced renal cell carcinoma (RCC) with high-dose interleukin-2 (rIL-2) or vinblastine (VLB).
    Sorio R; Galligioni E; Crivellari D; Talamini R; Monfardini S
    Ann Oncol; 1995 Mar; 6(3):306-7. PubMed ID: 7612500
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospective randomized trial of interferon alfa-2a plus vinblastine versus vinblastine alone in patients with advanced renal cell cancer.
    Pyrhönen S; Salminen E; Ruutu M; Lehtonen T; Nurmi M; Tammela T; Juusela H; Rintala E; Hietanen P; Kellokumpu-Lehtinen PL
    J Clin Oncol; 1999 Sep; 17(9):2859-67. PubMed ID: 10561363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined interferon and vinblastine treatment in advanced renal cell cancer.
    Kellokumpu-Lehtinen P; Jantunen I; Flander M; Johansson R; Nordman E
    Acta Oncol; 1995; 34(7):975-7. PubMed ID: 7492395
    [No Abstract]   [Full Text] [Related]  

  • 4. [Adjuvant chemotherapy with vinblastine, adriamycin and UFT (VAU) for renal cell carcinoma].
    Masuda F; Nakada J; Kondo I; Furuta N
    Gan To Kagaku Ryoho; 1991 Sep; 18(12):2143-6. PubMed ID: 1888185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of vinblastine plus nifedipine (VN) in patients with advanced renal cell carcinoma (RCC). Brazilian Oncology Trials Group.
    Schwartsmann G; Medina de Cunha F; Silveira LA; Salgado G; Thereza MS; Vinholes J; Preger P; Segal F
    Ann Oncol; 1991 Jun; 2(6):443. PubMed ID: 1768632
    [No Abstract]   [Full Text] [Related]  

  • 6. A phase II trial of vinblastine plus dipyridamole in advanced renal cell carcinoma. A Hoosier Oncology Group Study.
    Murphy BR; Rynard SM; Pennington KL; Grosh W; Loehrer PJ
    Am J Clin Oncol; 1994 Feb; 17(1):10-3. PubMed ID: 8311000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemotherapy of metastatic renal cell carcinoma: report of 28 cases.
    Wang HJ; Chen HX; Li HZ
    Chin Med J (Engl); 2005 Jan; 118(2):172-3. PubMed ID: 15667805
    [No Abstract]   [Full Text] [Related]  

  • 8. Interleukin-2, interferon-alpha, 5-fluorouracil, and vinblastine in the treatment of metastatic renal cell carcinoma: a prospective phase II study: the experience of Rambam and Lin Medical Centers 1996-2000.
    Gez E; Rubinov R; Gaitini D; Meretyk S; Best LA; Native O; Stein A; Erlich N; Beny A; Zidan J; Haim N; Kuten A
    Cancer; 2002 Oct; 95(8):1644-9. PubMed ID: 12365011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vinblastine and estramustine phosphate in metastatic renal cell carcinoma: a phase II trial of the Fox Chase Network.
    Haas NB; Giantonio BJ; Litwin S; Minniti CJ; Fox S; Yeslow G; Reilly R; Nahum K; Greenberg R; Halbherr T; Hudes GR
    Cancer; 2003 Nov; 98(9):1837-41. PubMed ID: 14584064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage therapy with sorafenib plus vinblastine and fluorouracil for metastatic renal cell carcinoma.
    Tai CJ
    Acta Oncol; 2009; 48(6):931-2. PubMed ID: 19925379
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II study of vinblastine and doxorubicin in advanced renal cell carcinoma.
    Jekunen A; Stengård J; Pyrhönen S
    Eur J Cancer; 1994; 30A(2):245. PubMed ID: 8155397
    [No Abstract]   [Full Text] [Related]  

  • 12. High-dose interleukin-2 may not be superior to low-dose interleukin-2 plus interferon.
    Alikhan M; Spencer HJ; Kohli M
    J Clin Oncol; 2005 Sep; 23(25):6267-8; author reply 6268-9. PubMed ID: 16135500
    [No Abstract]   [Full Text] [Related]  

  • 13. Metastatic renal cell carcinoma arising in a congenital solitary kidney. Treatment with interferon-containing combinations. A case report and a review of the literature.
    Merimsky O; Laufer R; Chaitchik S
    J Urol (Paris); 1989; 95(4):243-5. PubMed ID: 2529317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen and colchicine-modulated vinblastine followed by 5-fluorouracil in advanced renal cell carcinoma: a phase II study.
    Liu JH; Yang MH; Fan FS; Yen CC; Wang WS; Chang YH; Chen KK; Chen PM
    Urology; 2001 Apr; 57(4):650-4. PubMed ID: 11306370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of toremifene for reversal of multidrug resistance in renal cell cancer patients treated with vinblastine.
    Braybrooke JP; Vallis KA; Houlbrook S; Rockett H; Ellmén J; Anttila M; Ganesan TS; Harris AL; Talbot DC
    Cancer Chemother Pharmacol; 2000; 46(1):27-34. PubMed ID: 10912574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of recombinant interferon alpha-2a and vinblastine in advanced renal cell cancer.
    Bergerat JP; Herbrecht R; Dufour P; Jacqmin D; Bollack C; Prevot G; Bailly G; de Garis S; Juraschek F; Oberling F
    Cancer; 1988 Dec; 62(11):2320-4. PubMed ID: 3141036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy of advanced renal cell cancer with CCNU and vinblastine.
    Sommer HH; Fosså SD; Lien HH
    Cancer Chemother Pharmacol; 1985; 14(3):277-8. PubMed ID: 3995687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant low-dose interleukin-2 (IL-2) plus interferon-α (IFN-α) in operable renal cell carcinoma (RCC): a phase III, randomized, multicentre trial of the Italian Oncology Group for Clinical Research (GOIRC).
    Passalacqua R; Caminiti C; Buti S; Porta C; Camisa R; Braglia L; Tomasello G; Vaglio A; Labianca R; Rondini E; Sabbatini R; Nastasi G; Artioli F; Prati A; Potenzoni M; Pezzuolo D; Oliva E; Alberici F; Buzio C;
    J Immunother; 2014; 37(9):440-7. PubMed ID: 25304727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant interferon-alpha 2a and vinblastine in advanced renal cell cancer: a clinical phase I-II study.
    Kellokumpu-Lehtinen P; Nordman E
    J Biol Response Mod; 1990 Aug; 9(4):439-44. PubMed ID: 2395008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [First-line therapy for German patients with metastatic kidney neoplasms in EORTC-Protocol 30012].
    Rexer H
    Urologe A; 2004 Aug; 43(8):992-3. PubMed ID: 15316609
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.